EPHEDRINE SULFATE

N/A

Manufactured by Foundation Consumer Healthcare LLC

545 FDA adverse event reports analyzed

Last updated: 2026-04-15

About EPHEDRINE SULFATE

EPHEDRINE SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Foundation Consumer Healthcare LLC. The most commonly reported adverse reactions for EPHEDRINE SULFATE include DRUG INEFFECTIVE, OFF LABEL USE, DRUG ABUSE, CARDIAC ARREST, OVERDOSE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for EPHEDRINE SULFATE.

Top Adverse Reactions

DRUG INEFFECTIVE32 reports
OFF LABEL USE16 reports
DRUG ABUSE15 reports
CARDIAC ARREST13 reports
OVERDOSE13 reports
TOXICITY TO VARIOUS AGENTS13 reports
DRUG DEPENDENCE11 reports
RESPIRATORY ARREST11 reports
ADMINISTRATION RELATED REACTION10 reports
DRUG HYPERSENSITIVITY10 reports
HYPOTENSION10 reports
NO ADVERSE EVENT10 reports
ACUTE KIDNEY INJURY9 reports
ANXIETY9 reports
DIZZINESS9 reports
DYSPNOEA9 reports
PAIN9 reports
ASTHENIA8 reports
BACK PAIN8 reports
BLOOD PRESSURE INCREASED8 reports
FATIGUE8 reports
LOSS OF CONSCIOUSNESS8 reports
NAUSEA8 reports
COUGH7 reports
BRADYCARDIA6 reports
DIABETES MELLITUS6 reports
INCORRECT DRUG ADMINISTRATION DURATION6 reports
INJURY6 reports
INSOMNIA6 reports
MUSCULAR WEAKNESS6 reports
RENAL FAILURE6 reports
TACHYCARDIA6 reports
ANAPHYLACTIC REACTION5 reports
ATRIAL FIBRILLATION5 reports
COVID 195 reports
FEELING ABNORMAL5 reports
HYPERTENSION5 reports
NERVOUSNESS5 reports
PNEUMONIA5 reports
PRODUCT PACKAGING CONFUSION5 reports
ADVERSE EVENT4 reports
ANAPHYLACTIC SHOCK4 reports
CHRONIC KIDNEY DISEASE4 reports
CONDITION AGGRAVATED4 reports
CONSTIPATION4 reports
DERMATITIS ALLERGIC4 reports
GAIT DISTURBANCE4 reports
HAEMODYNAMIC INSTABILITY4 reports
HEART RATE INCREASED4 reports
HYPERTHERMIA4 reports
MALAISE4 reports
MYOCARDIAL INFARCTION4 reports
OEDEMA4 reports
PAIN IN EXTREMITY4 reports
PARAESTHESIA4 reports
RHABDOMYOLYSIS4 reports
SINUSITIS4 reports
TREMOR4 reports
UNEVALUABLE EVENT4 reports
VENTRICULAR TACHYCARDIA4 reports
VOMITING4 reports
WEIGHT DECREASED4 reports
ABDOMINAL DISTENSION3 reports
ARTERIOSPASM CORONARY3 reports
CARDIAC FAILURE3 reports
CELLULITIS3 reports
CHEST DISCOMFORT3 reports
CHEST PAIN3 reports
DEPRESSION3 reports
DIARRHOEA3 reports
DRUG ABUSER3 reports
FALL3 reports
GASTROOESOPHAGEAL REFLUX DISEASE3 reports
HEADACHE3 reports
HEART RATE DECREASED3 reports
HYPERSENSITIVITY3 reports
INCORRECT DOSE ADMINISTERED3 reports
INFECTION3 reports
INTENTIONAL PRODUCT MISUSE3 reports
MUSCLE SPASMS3 reports
MYALGIA3 reports
NASOPHARYNGITIS3 reports
OSTEOMYELITIS3 reports
OSTEONECROSIS OF JAW3 reports
PAIN IN JAW3 reports
PRODUCT QUALITY ISSUE3 reports
RHINORRHOEA3 reports
RIB FRACTURE3 reports
STRESS3 reports
STRESS CARDIOMYOPATHY3 reports
URINARY TRACT INFECTION3 reports
AGITATION2 reports
ALANINE AMINOTRANSFERASE INCREASED2 reports
ALOPECIA2 reports
ANAEMIA2 reports
ARTHRALGIA2 reports
ASTHMA2 reports
BALANCE DISORDER2 reports
BLOOD PRESSURE SYSTOLIC INCREASED2 reports
CARDIAC DISORDER2 reports

Report Outcomes

Out of 206 classified reports for EPHEDRINE SULFATE:

Serious 72.8%Non-Serious 27.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male80 (49.1%)
Female79 (48.5%)
Unknown4 (2.5%)

Reports by Age

Age 5011 reports
Age 566 reports
Age 465 reports
Age 615 reports
Age 695 reports
Age 795 reports
Age 434 reports
Age 714 reports
Age 734 reports
Age 744 reports
Age 323 reports
Age 333 reports
Age 353 reports
Age 373 reports
Age 523 reports
Age 593 reports
Age 603 reports
Age 623 reports
Age 633 reports
Age 723 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with EPHEDRINE SULFATE?

This profile reflects 545 FDA FAERS reports that mention EPHEDRINE SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for EPHEDRINE SULFATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, DRUG ABUSE, CARDIAC ARREST, OVERDOSE, TOXICITY TO VARIOUS AGENTS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures EPHEDRINE SULFATE?

Labeling and FAERS entries often list Foundation Consumer Healthcare LLC in connection with EPHEDRINE SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.